Literature DB >> 24236853

Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression.

Nam Nguyen1, Celine de Esch, Barbara Cameron, Rakesh K Kumar, Amany Zekry, Andrew R Lloyd.   

Abstract

BACKGROUND AND AIM: Chronic hepatitis C virus infection is characterized by infiltration of a mixed population of leukocytes into portal tracts and infiltration almost exclusively by CD8+ T cells into lobules of the liver. This pattern of leukocyte recruitment is likely to be orchestrated in a cell-specific fashion by local chemokine expression.
METHODS: Portal or lobular tissues were isolated by laser capture microdissection from 17 liver biopsy specimens to examine regional gene expression of a panel of chemokine ligands and receptors. The biopsies were also stained immunohistochemically to enumerate regional cell numbers.
RESULTS: Expression of multiple chemokine ligands and receptors was evident, although few correlated with leukocyte numbers. In the lobule, expression of CXCL10 correlated with T-cell subsets (CD3+, P = 0.0002; CD4+, P = 0.0053; and CD8+, P = 0.0061), as did CCL5 (CD3+, P = 0.0005; CD8+, P = 0.0199) and CCL3 (CD3+, P = 0.0016; CD8+, P = 0.008). In the portal tracts, expression of CXCL10 and CCL5 was correlated with CD8+ T-cell numbers (P = 0.0040 and P = 0.0114, respectively), whereas CXCL13 was strongly correlated with CD20+ B-cell numbers (P < 0.0001). CXCR3 expression correlated with CD3+ and CD4+ T cells (P < 0.0001 and P = 0.0208, respectively), CCR5 with CD8+ T cells (P < 0.0001), and CXCR5 with CD20+ B-cell infiltration (P = 0.0022).
CONCLUSION: CXCR3, CCR5, and CXCR5 and their ligands form key elements of the "zip code" responsible for regional localization of specific lymphocyte subsets in the HCV-infected liver.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  chemokines; leukocytes; lobules; portal tracts; trafficking

Mesh:

Substances:

Year:  2014        PMID: 24236853     DOI: 10.1111/jgh.12462

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  Genetic variants in chemokine CC subfamily genes influence hepatitis C virus viral clearance.

Authors:  Yinan Yao; Ming Yue; Feng Zang; Mei Liu; Haozhi Fan; Lingyun Zhuo; Jingjing Wu; Xueshan Xia; Yue Feng; Peng Huang; Rongbin Yu
Journal:  J Hum Genet       Date:  2018-04-27       Impact factor: 3.172

2.  Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy.

Authors:  Eric G Meissner; Jérémie Decalf; Armanda Casrouge; Henry Masur; Shyam Kottilil; Matthew L Albert; Darragh Duffy
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240

3.  Phenotype and function of CXCR5+CD45RA-CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis.

Authors:  Zhaojun Duan; Jian Gao; Ling Zhang; Hua Liang; Xiangbo Huang; Qiang Xu; Yu Zhang; Tao Shen; Fengmin Lu
Journal:  Oncotarget       Date:  2015-12-29

4.  Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation.

Authors:  Victoria L Gadd; Preya J Patel; Sara Jose; Leigh Horsfall; Elizabeth E Powell; Katharine M Irvine
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

5.  Endotoxemia contributes to CD27+ memory B-cell apoptosis via enhanced sensitivity to Fas ligation in patients with Cirrhosis.

Authors:  Li-Yuan Chang; Yonghai Li; David E Kaplan
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

6.  Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy.

Authors:  Chao Liu; Xuan Huang; Melanie Werner; Ruth Broering; Jun Ge; Yongyin Li; Baolin Liao; Jian Sun; Jie Peng; Mengji Lu; Jinlin Hou; Xiaoyong Zhang
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

Review 7.  Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C?

Authors:  Silvia Martina Ferrari; Poupak Fallahi; Ilaria Ruffilli; Giusy Elia; Francesca Ragusa; Sabrina Rosaria Paparo; Armando Patrizio; Valeria Mazzi; Michele Colaci; Dilia Giuggioli; Clodoveo Ferri; Alessandro Antonelli
Journal:  J Immunol Res       Date:  2019-08-08       Impact factor: 4.818

Review 8.  The role of chemokines in hepatitis C virus-mediated liver disease.

Authors:  Anette Brass; Erwin Daniel Brenndörfer
Journal:  Int J Mol Sci       Date:  2014-03-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.